Documents
Application Sponsors
NDA 204957 | B BRAUN MEDICAL INC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | SOLUTION;INTRAVENOUS | 1GM/100ML?(10MG/ML) | 0 | ACETAMINOPHEN | ACETAMINOPHEN |
002 | SOLUTION;INTRAVENOUS | 500MG/50ML?(10MG/ML) | 0 | ACETAMINOPHEN | ACETAMINOPHEN |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2021-02-18 | STANDARD |
Submissions Property Types
CDER Filings
B BRAUN MEDICAL INC
cder:Array
(
[0] => Array
(
[ApplNo] => 204957
[companyName] => B BRAUN MEDICAL INC
[docInserts] => ["",""]
[products] => [{"drugName":"ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN","strength":"1GM\/100ML\u00a0(10MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN","strength":"500MG\/50ML\u00a0(10MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"02\/18\/2021","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/204957s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"02\/18\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/204957s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/204957Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2021-02-18
)
)